924271-33-0Relevant academic research and scientific papers
THERAPEUTIC COMPOUNDS
-
Paragraph 0148, (2018/07/06)
no abstract published
Macrocyclic Compounds as Antiviral Agents
-
, (2009/12/27)
The present invention relates to macrocyclic compounds of formula (I): wherein W, n, m, R1, R2, R3, R4, R5, Ra, M, Z and ring B are defined herein, and pharmaceutically acceptable salts the
HCV NS3 PROTEASE INHIBITORS
-
Page/Page column 36, (2008/12/05)
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
HCV NS3 PROTEASE INHIBITORS
-
Page/Page column 44, (2008/12/05)
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
